Skip to main content

Day: May 26, 2022

IHT TO ANNOUNCE POSITIVE FISCAL YEAR OPERATING RESULTS SHORTLY, WITH 10-K FILING DELAYED

Phoenix, AZ, May 26, 2022 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) will be reporting shortly Results for Fiscal Year 2022 (February 1, 2021, to January 31, 2022), as well as solid revenues for Q1 of 2023 (February 1, 2022, to April 30, 2022). On May 18, 2022, the Trust received a letter from the NYSE Regulation Department, informing the Trust it had not timely filed its annual report with the Securities and Exchange Commission (the “SEC”) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Accordingly, the NYSE Regulation’s official notice of noncompliance with NYSE American continued listing standards (“Filing Delinquency Notification”), was received. The Trust is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the “Company...

Continue reading

Eagle Pharmaceuticals to Present at the William Blair 42nd Annual Growth Stock Conference

WOODCLIFF LAKE, N.J., May 26, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”) today announced that Scott Tarriff, President and Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the William Blair 42nd Annual Growth Stock Conference as follows:Date: Thursday, June 9, 2022   Time: 9:40AM ET/8:40AM CT   Webcast: Click Here   About Eagle Pharmaceuticals, Inc. Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include vasopressin injection, PEMFEXY™, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM (Japan), and its oncology and CNS/metabolic...

Continue reading

Saratoga Investment Corp. Declares Quarterly Dividend of $0.53 per Share for the Fiscal First Quarter Ended May 31, 2022

Contact: Henri SteenkampSaratoga Investment Corp.212-906-7800 __________________________________________ NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company, today announced that its Board of Directors has declared a quarterly dividend of $0.53 per share for the fiscal first quarter ended May 31, 2022, payable on June 29, 2022, to all stockholders of record at the close of business on June 14, 2022. “Our continued strong track record and portfolio performance, healthy credit profile, robust deal pipeline, and ongoing asset growth are key attributes of our ability to deliver consistent financial performance and support a program of paying quarterly dividends,” said Christian L. Oberbeck, Chairman and Chief Executive Officer of Saratoga...

Continue reading

Burlington Stores, Inc. Announces Appointment of Kristin Wolfe as Chief Financial Officer

BURLINGTON, N.J., May 26, 2022 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced that Kristin Wolfe has been appointed Chief Financial Officer effective on or about August 1, 2022. As previously announced, the employment of John Crimmins, the Company’s current Chief Financial Officer, will end on August 31, 2022.  The month overlap will allow for both executives to transition, and Mr. Crimmins will provide consulting services to the Company through the end of February 2023.  Ms. Wolfe joins Burlington from Ross Stores, Inc., where she served in a wide range of financial, strategic and operational roles. Ms. Wolfe most recently served as Ross Stores’ Group...

Continue reading

Burlington Stores, Inc. Reports First Quarter 2022 Earnings

All First Quarter 2022 comparisons are made versus the First Quarter 2021On a GAAP basis, total sales decreased 12%, net income was $16 million, and diluted EPS was $0.24 Comparable store sales decreased 18% On a non-GAAP basis, Adjusted EBIT was $59 million, a decrease of 780 basis points as a percentage of sales On a non-GAAP basis, Adjusted EPS was $0.54BURLINGTON, N.J., May 26, 2022 (GLOBE NEWSWIRE) — Burlington Stores, Inc. (NYSE: BURL), a nationally recognized off-price retailer of high-quality, branded apparel, footwear, accessories, and merchandise for the home at everyday low prices, today announced its results for the first quarter ended April 30, 2022. Michael O’Sullivan, CEO, stated, “We are disappointed with our first quarter results. We were up against 20% comp growth from 2021 so we had planned for a mid-teens...

Continue reading

Titan Machinery Inc. Announces Results for Fiscal First Quarter Ended April 30, 2022

– Revenue for First Quarter of Fiscal 2023 Increased 23.7% to $461.0 million – – EPS for First Quarter of Fiscal 2023 was $0.78 and Adjusted EPS was $0.79 – – Increases Fiscal 2023 Modeling Assumptions, Expects Fiscal 2023 EPS in Range of $2.85-$3.15 – WEST FARGO, N.D., May 26, 2022 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, today reported financial results for the fiscal first quarter ended April 30, 2022. David Meyer, Titan Machinery’s Chairman and Chief Executive Officer, stated, “Our momentum continued into fiscal first quarter 2023 with strong operating leverage across each of our segments, which combined for a 24% increase in revenue and a 66% increase in earnings per share. Our Agriculture...

Continue reading

Portable Power Station Market Size Worth USD 439.3 Million, Globally, by 2028 at 8.7% CAGR: Fortune Business Insights™

Portable Power Station Market to Exhibit a CAGR of 8.7% by 2028; Rising Cases of Power Outages to Bolster Market Growth. Increasing Smart Device Adoption to Fuel the Market Development. Pune, India, May 26, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global portable power station market size is anticipated to hit USD 439.3 million by 2028 from USD 244.5 million in 2021 and exhibit a CAGR of 8.7% during the forecast period. The global Portable Power Station market size stood at USD 238.1 million in 2020. Fortune Business Insights™ mentions this information in its report titled Portable power station Market, 2021-2028. The rising adoption of smart devices is likely to fuel the product adoption. Developments in digital infrastructure, rising smart-electronics adoption, and 5G technology developments have increased...

Continue reading

Fusion Fuel Green Hosts First Quarter 2022 Investor Update

SABUGO, Portugal, May 26, 2022 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel”), an emerging leader in the green hydrogen sector, today announced financial results for the first quarter ended March 31, 2022. The quarterly shareholder letter is available at https://ir.fusion-fuel.eu/financials-filings/earnings-releases Fusion Fuel will host a live conference call and webcast today, May 26, 2022.Time: 10:00am ET / 3:00pm WEST Participant Dial-In: +1 (312) 248-9348Participant ID: 889672 Participant Passcode: 8176Webcast registration page: https://www.bigmarker.com/izigo/Q1-Update-Fusion-FuelThe webcast may also be accessed through the Events page on the Fusion Fuel website (www.fusion-fuel.eu). A playback will be available for replay online for a period of time following the call. About...

Continue reading

Antipsychotic Drugs Market Size [2022-2029]: $24.74 Billion by 2029 at CAGR of 6.9%

According to Fortune Business Insights, The global antipsychotic drugs market size is predicted to hit USD 24.74 billion by 2029 and exhibit a CAGR of 6.9% during the forecast period. Biopharmaceutical Companies’ Presence to Proliferate Market Growth in North America Pune, India, May 26, 2022 (GLOBE NEWSWIRE) — The global antipsychotic drugs market size is predicted to hit USD 24.74 billion by 2029 and exhibit a CAGR of 6.9% during the forecast period. The expanding patient pool of mental health disorders is estimated to foster growth for the market. In 2022, the World Health Organization (WHO) published an estimation of approximately 24 million people suffering from Schizophrenia globally. Fortune Business InsightsTM has presented this information in its report titled, “Antipsychotic Drugs Market, 2022-2029”. As per the report,...

Continue reading

Myasthenia Gravis Treatment Market Size [2022-2029]: $2.03 Billion by 2028 at CAGR of 7.5%

According to Fortune Business Insights, The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast period. Rising Geriatric Population in North America to Augment Market Growth Pune, India, May 26, 2022 (GLOBE NEWSWIRE) — The global myasthenia gravis treatment market size is anticipated to reach USD 2.03 billion by 2028 and exhibit a CAGR of 7.5% during the forecast period. Fortune Business InsightsTM has presented this information in its report titled, “Myasthenia Gravis Treatment, 2021-2028”. The market size stood at USD 1.15 billion in 2020 and is expected to reach USD 1.22 billion in 2021. Additionally, the rising geriatric population is expected to be a significant market growth driver. Myasthenia Gravis Treatment Industry Developments- March...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.